JP2010520851A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520851A5
JP2010520851A5 JP2009528597A JP2009528597A JP2010520851A5 JP 2010520851 A5 JP2010520851 A5 JP 2010520851A5 JP 2009528597 A JP2009528597 A JP 2009528597A JP 2009528597 A JP2009528597 A JP 2009528597A JP 2010520851 A5 JP2010520851 A5 JP 2010520851A5
Authority
JP
Japan
Prior art keywords
preferred
formula
acyl
alkyl
ring members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009528597A
Other languages
English (en)
Other versions
JP2010520851A (ja
JP5588172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DE2007/001768 external-priority patent/WO2008040332A1/de
Publication of JP2010520851A publication Critical patent/JP2010520851A/ja
Publication of JP2010520851A5 publication Critical patent/JP2010520851A5/ja
Application granted granted Critical
Publication of JP5588172B2 publication Critical patent/JP5588172B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明の好ましい実施態様では、Aおよび/またはBは5および/または6個の環原子であるように選択され、AおよびBで表される環員はC、O、Sおよび/またはN原子からなる群から選択される。当然、4、5、または6員環が形成され、環員が‐CH‐、‐O‐、‐S‐および
Figure 2010520851
(RがH、アルキルまたはアシル)から構成されるような架橋環A、Bを選択することも好ましい。
本発明の別の好ましい実施態様では、化合物は一般式2を有する:
Figure 2010520851
、Zは式1で示したものと同じであり、その立体配置は式2に示され;
、R2がアルキル、アシル、ヘタリールおよび/またはスルホニルであり、
Xが‐CH‐、‐O‐、‐S‐および/または
Figure 2010520851
である。
JP2009528597A 2006-09-25 2007-09-25 プロリンが豊富なペプチドの構造的模倣薬およびその医薬用途 Active JP5588172B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP06090178 2006-09-25
EP06090178.2 2006-09-25
EP06090179 2006-09-25
EP06090179.0 2006-09-25
DE102006057070.7 2006-11-29
DE102006057070 2006-11-29
EP07090095.6 2007-05-07
EP07090095 2007-05-07
PCT/DE2007/001768 WO2008040332A1 (de) 2006-09-25 2007-09-25 Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung

Publications (3)

Publication Number Publication Date
JP2010520851A JP2010520851A (ja) 2010-06-17
JP2010520851A5 true JP2010520851A5 (ja) 2011-09-01
JP5588172B2 JP5588172B2 (ja) 2014-09-10

Family

ID=38962788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009528597A Active JP5588172B2 (ja) 2006-09-25 2007-09-25 プロリンが豊富なペプチドの構造的模倣薬およびその医薬用途

Country Status (4)

Country Link
US (1) US8242105B2 (ja)
EP (1) EP2094711B8 (ja)
JP (1) JP5588172B2 (ja)
WO (1) WO2008040332A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518933B2 (en) 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
DE102009032902A1 (de) 2009-07-10 2011-01-13 Forschungsverbund Berlin E.V. Induktion von α-Helix-Konformationen in Proteinen und Peptiden
US8362311B2 (en) 2009-09-30 2013-01-29 Massachusetts Institute Of Technology Highly Z-selective olefins metathesis
EP2561873A1 (de) * 2011-08-26 2013-02-27 Forschungsverbund Berlin e.V. Strukturmimetika prolinreicher Peptide und ihre Verwendung
WO2014147484A2 (en) 2013-03-21 2014-09-25 Caprion Proteomics Inc. Brucellosis, q-fever, and lyme disease biomarkers and uses thereof
CA2913418C (en) 2013-05-29 2021-11-23 Vybion, Inc. Single chain intrabodies that alter huntingtin mutant degradation
WO2016092069A1 (de) 2014-12-11 2016-06-16 Forschungsverbund Berlin E.V. Inhibitoren zur hemmung der tumormetastasierung
KR101729236B1 (ko) * 2015-06-01 2017-04-21 (주)노터스생명과학 Tlr7 항진제를 포함하는 비만 또는 간질환 예방 및 치료용 약학 조성물
WO2017170924A1 (ja) * 2016-03-31 2017-10-05 千寿製薬株式会社 神経保護ペプチド
EP3759108B1 (de) 2018-02-26 2023-08-30 Forschungsverbund Berlin E.V. Polyprolin-mimetika des prolin-abgeleiteten moduls-15

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860600A (en) * 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
DD277681A1 (de) * 1988-12-05 1990-04-11 Akad Wissenschaften Ddr Verfahren zur herstellung von (5h-2,3-dihydro-5-oxo-thiazolo-[2,3-b]chinazolinyl)-alkanoylaminosaeuren und deren estern
ATE233764T1 (de) * 1997-09-29 2003-03-15 Meiji Seika Kaisha Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel
US6235877B1 (en) 1999-08-04 2001-05-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
ITMI20050328A1 (it) 2005-03-03 2006-09-04 Univ Degli Studi Milano Composti peptidomimetrici e preparazione di derivati biologicamente attivi

Similar Documents

Publication Publication Date Title
JP2010520851A5 (ja)
JP2010501534A5 (ja)
JP2009535462A5 (ja)
JP2015181191A5 (ja)
JP2011518833A5 (ja)
JP2010536766A5 (ja)
JP2018024670A5 (ja)
JP2007523139A5 (ja)
JP2015523439A5 (ja) 量子ドット結合用リガンド及び組成物
JP2008505932A5 (ja)
JP2015522045A5 (ja)
JP2009511508A5 (ja)
JP2012092103A5 (ja)
JP2010504908A5 (ja)
JP2013102146A5 (ja) 化合物
JP2008500997A5 (ja)
JP2013010749A5 (ja) カルバゾール化合物
JP2007500753A5 (ja)
JP2009536221A5 (ja)
JP2009013167A5 (ja) 有機金属錯体、発光材料、発光素子、及び発光装置
JP2021502388A5 (ja)
JP2010508335A5 (ja)
JP2016501520A5 (ja)
JP2005289914A5 (ja)
JP2011510079A5 (ja)